Their pro-tumor mechanisms involve multiple levels: (1) Direct pro-tumor effects: CNIs can enhance tumor angiogenesis and invasiveness by upregulating IFI27/VEGFA [59], and activate proto-oncogenes and enhance TGF-β expression in a dose-dependent manner, thereby promoting recurrence and metastasis [60]. The gene discussed is VEGFA; the disease is neoplasm.